Mark W. Zimmerman
- Molecular Biology
- Neurology top 5%
- Cancer Research top 10%
- Oncology
- Cell Biology
- Co-authors
- A. Thomas LookAdam D. DurbinBrian J. AbrahamShuning HeRichard A. YoungJohn S. LazoGregg E. HomanicsNina Weichert‐Leahey
- Topics
- Neuroblastoma Research and Treatments (15 papers)Protein Degradation and Inhibitors (7 papers)Signaling Pathways in Disease (4 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Mark W. Zimmerman
22 papers receiving 704 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 530
- Neurology 319
- Cancer Research 170
- Oncology 121
- Cell Biology 86
Countries citing papers authored by Mark W. Zimmerman
This map shows the geographic impact of Mark W. Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Zimmerman more than expected).
Fields of papers citing papers by Mark W. Zimmerman
This network shows the impact of papers produced by Mark W. Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Zimmerman. The network helps show where Mark W. Zimmerman may publish in the future.
Co-authorship network of co-authors of Mark W. Zimmerman
This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Zimmerman. A scholar is included among the top collaborators of Mark W. Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Zimmerman. Mark W. Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 54 | |
| 10 | 36 | |
| 11 | 145 | |
| 12 | c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification | 2 |
| 13 | 147 | |
| 14 | 1 | |
| 15 | 12 | |
| 16 | 0 | |
| 17 | Opening the Door to Race-Based Real Estate Marketing: South-Suburban Housing Center v. Greater South Suburban Board of Realtors | 0 |
| 18 | 44 | |
| 19 | 16 | |
| 20 | 53 |
About Mark W. Zimmerman
Mark W. Zimmerman is a scholar working on Neurology, Molecular Biology and Immunology, having authored 24 papers that have together received 706 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (15 papers), Protein Degradation and Inhibitors (7 papers) and Signaling Pathways in Disease (4 papers). The work is most often cited by research in Neurology (319 citations), Cancer Research (170 citations) and Molecular Biology (530 citations). Mark W. Zimmerman has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include A. Thomas Look, Adam D. Durbin, Brian J. Abraham, Shuning He, Richard A. Young, John S. Lazo, Gregg E. Homanics, Nina Weichert‐Leahey, Ting Tao and Hui Shi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.